Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Sugar Solution Turns Tissues See-Through

By BiotechDaily International staff writers
Posted on 09 Jul 2013
Image: Various mouse tissues before and after immersion in SeeDB (Photo courtesy of RIKEN).
Image: Various mouse tissues before and after immersion in SeeDB (Photo courtesy of RIKEN).
A new study describes a sugar and water-based solution that turns tissues transparent in just three days, without disrupting the shape and chemical nature of the samples.

Researchers at the RIKEN Center for Developmental Biology (Kobe, Japan), Kyoto University (Japan), and the Japan Science and Technology Agency (JST; Saitama, Japan) have developed SeeDB, an aqueous fructose optical clearing agent they used to turn mouse embryos and brains transparent in just three days, without damaging the fine structures of the samples or the fluorescent dyes they had injected in them, allowing visualization of the neuronal circuitry at the whole-brain scale under a customized fluorescence microscope without making mechanical sections through the brain.

Combined with two-photon microscopy and an optimized objective lens, the researchers were also able to image the mouse brain from the dorsal to the ventral side, describing the detailed wiring patterns of commissural fibers connecting the right and left hemispheres of the cerebral cortex in three dimensions (3D) and were also able to visualize the 3D wiring of mitral cells in the olfactory bulb (which is involved the detection of smells), at single-fiber resolution. The study was published online on June 23, 2013, in Nature Neuroscience.

“Our simple and efficient method is useful for imaging intact morphological architecture at large scales in both the adult and developing brains,” concluded lead author Takeshi Imai, PhD, of RIKEN, and colleagues. “Because SeeDB is inexpensive, quick, easy and safe to use, and requires no special equipment, it will prove useful for a broad range of studies, including the study of neuronal circuits in human samples.”

Tissue optical clearing techniques provide a prospective solution for the application of advanced optical methods in life sciences, including physical methods, chemical-penetration enhancers, and a combination of methods. Difference in the diffusion and/or clearing ability of different clearing agents for soft or hard tissue can aid in-vivo imaging and phototherapy, as well as providing a highly sensitive indicator of tissue health or pathology condition.

Related Links:

RIKEN Center for Developmental Biology
Kyoto University
Japan Science and Technology Agency



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Alternative splicing produces two protein isoforms (Photo courtesy of Wikimedia Commons).

Key Regulator of Cancer-Inducing Alternative Splicing Identified

Cancer researchers have identified the splicing factor RBM4 (RNA-binding protein 4) as a key determinant in processes that prevent tumor development and spread. RBM4 is known to be crucial to gene splicing... Read more

Drug Discovery

view channel

Ibuprofen May Restore Immune Function in Older Individuals

New research suggests that macrophages from the lungs of old mice respond differently to infections than those of young mice, and ibuprofen given to the mice reversed these changes. New research using lab mice suggests that the solution to more youthful immune function might already be a common over-the-counter pain reliever.... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.